3
- Authors: Siragusa, S; Malato, A; Mascheroni, D; Ageno, W; Bucherini, E; Spadaro, P; Imberti, D; Saccullo, G; Lo Coco, L; Rotondo, S; Santoro, R; Di Micco, P; Oriana P;, Urbano, O; Prantera, T; Recchia, F; D'Alessio, A;Gallucci, P; Ghirarduzzi, A; Cormaci, O; Caracciolo, C; Abbadessa, V
- Publication year: 2010
- Type: eedings
- Key words: cancer, venous thrombosis
- OA Link: http://hdl.handle.net/10447/58595
Abstract
The Optimal Duration of Anticoagulant Therapy In Patients with Cancer-Related Deep Vein Thrombosis: The Advantage of Using Residual Vein Thrombosis (the Cancer-DACUS Study)